Search Results (1,625)

Chronic wound infections present a persistent medical challenge; however, advancements in wound dressings and antimicrobial nanomaterials offer promising solutions for improving healing outcomes. This study introduces a hydrothermal synthesis approach for producing zinc oxide (ZnO) and copper oxide (CuO) nanoparticles, subsequently incorporated into PLGA microspheres and embedded within collagen hydrogels. The nanoparticles’ physicochemical properties were characterized using X-ray diffraction (XRD) to confirm crystalline structure, scanning electron microscopy (SEM) for surface morphology, and Fourier-transform infrared spectroscopy (FT-IR) to verify functional groups and successful hydrogel integration. The hydrogels were tested for antimicrobial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans, which are key pathogens in chronic wounds. Biocompatibility was assessed using the human HaCat keratinocyte cell line. Both ZnO- and CuO-loaded hydrogels exhibited broad-spectrum antimicrobial efficacy. Cytocompatibility tests demonstrated that both ZnO- and CuO-loaded hydrogels sustain cell viability and proliferation, highlighting their biocompatibility and suitability for chronic wound healing applications, with superior biological performance of ZnO-loaded hydrogels. Furthermore, the distinct antimicrobial profiles of ZnO and CuO hydrogels suggest their tailored use based on wound microbial composition, with CuO hydrogels excelling in antibacterial applications and ZnO hydrogels showing potential for antifungal treatments. These results underscore the potential of nanoparticle-based collagen hydrogels as innovative therapeutic tools for managing chronic wounds. Full article

Chitosan is an attractive material for developing inks for extrusion-based bioprinting of 3D structures owing to its excellent properties, including its mechanical properties and antimicrobial activity when used in wound dressings. A key challenge in formulating chitosan-based inks is to improve its gelation property to ensure reliable printing and the mechanical stability of the printed structures. To address these challenges, this article presents a novel chitosan/oxidized glucomannan composite hydrogel obtained through the combination of Schiff base and phenol crosslinking reactions. The proposed biomaterial forms soft hydrogels through Schiff base crosslinking, which can be further stabilized via visible light-induced phenol crosslinking. This dual-crosslinking approach enhances the printability and robustness of chitosan-based ink materials. The proposed chitosan/oxidized glucomannan hydrogel exhibits excellent extrudability and improved shape retention after extrusion, along with antimicrobial properties against Escherichia coli. Moreover, good cytocompatibility was confirmed in animal cell studies using mouse fibroblast 10T1/2 cells. These favorable features make this hydrogel highly promising for the extrusion-based bioprinting of complex 3D structures, such as tubes and nose-like structures, at a low crosslinker concentration and can expand the prospects of chitosan in bioprinting, providing a safer and more efficient alternative for tissue engineering and other biomedical applications. Full article

Hydrogels and microgels are emerging as pivotal platforms in biomedicine, with significant potential in targeted drug delivery, enhanced infection management, and tissue repair and regeneration. These gels, characterized by their high water content, unique structures, and adaptable mechanical properties, interact seamlessly with biological systems, making them invaluable for controlled and targeted drug release. In the realm of infection management, hydrogels and microgels can incorporate antimicrobial agents, offering robust defenses against bacterial infections. This capability is increasingly important in the fight against antibiotic resistance, providing innovative solutions for infection prevention in wound dressings, surgical implants, and medical devices. Additionally, the biocompatibility and customizable mechanical properties of these gels make them ideal scaffolds for tissue engineering, supporting the growth and repair of damaged tissues. Despite their promising applications, challenges such as ensuring long-term stability, enhancing therapeutic agent loading capacities, and scaling production must be addressed for widespread adoption. This review explores the current advancements, opportunities, and limitations of hydrogels and microgels, highlighting research and technological directions poised to revolutionize treatment strategies through personalized and regenerative approaches. Full article

Chronic or improperly healed wounds, either as a result of extended trauma or prolonged inflammatory response, affect a significant percentage of the world population. Hence, there is a growing interest in the development of biomimetic scaffolds that expedite wound closure at the early stages. Curcumin (Cur) is a plant-derived polyphenol with antimicrobial activity, and it accelerates the wound contraction rate. Recently, electrospraying has emerged for the precise deposition of bioactive molecules into scaffolds to improve therapeutic outcomes. In this study, we produced membranes for wound healing and endowed them with antibacterial properties to promote the healing of impaired wounds. Unlike previous studies that incorporated curcumin directly into electrospun fibers, we employed electrospraying to coat curcumin onto PVA/KC membranes. This approach improves the curcumin bioavailability and release kinetics, ensuring sustained therapeutic action. Toward this end, we fabricated four types of membranes, poly(vinyl alcohol) PVA and PVA/kappa carrageenan (KC), using electrospinning, and PVA/KC/Cur5 and PVA/KC/Cur20, in which the PVA/KC membranes were coated with two different concentrations of Cur by electrospraying. All membranes showed low cytotoxicity, good cell adhesion, the capability of enabling cells to produce collagen, and an adequate degradation rate for wound-healing applications. Antibacterial evaluation showed that both Cur-loaded membranes increased the antibacterial efficacy against both Escherichia coli and Staphylococcus aureus compared with PVA and PVA/KC membranes. These findings highlight the potential of electrosprayed curcumin as an effective strategy for bioactive wound dressings. Full article

Background/Objectives: Surgical Site Infections (SSIs) rank among the most common complications following stoma takedown and lead to increased morbidity, increased Length of Hospital Stay (LOS), and higher healthcare costs. Negative Pressure Wound Therapy (NPWT) systems have emerged as a promising option for optimizing wound management and minimizing SSI rates. This systematic review and meta-analysis compares postoperative outcomes of NPWT and conventional Non-Pressure Dressings following stoma reversal. Methods: A search of the literature published up to 1 September 2024 was conducted across MEDLINE/PubMed, and the Cochrane Central Register of Controlled Trials (CENTRAL), and Scopus, as well as ClinicalTrials.gov. Only Randomized Controlled Trials (RCTs) were included. The primary outcome was SSI rate, while secondary outcomes included time to complete wound healing, LOS, and patient-reported wound cosmesis. Quality assessment was performed using the Cochrane Risk of Bias 2 (RoB 2) tool. The results were synthesized using means and Standard Deviations for continuous variables, counts and percentages for categorical variables, and presented as Odds Ratios (OR) or Mean Differences (MD) with 95% Confidence Intervals, using random or fixed effects models based on heterogeneity (I²). Results: Six RCTs, including 328 patients, were ultimately eligible for inclusion. No significant difference was revealed in SSI rates between the NPWT and conventional dressing groups (OR = 0.95; 95% CI: 0.27–3.29; p = 0.94; I² = 38%). Time to complete wound healing was significantly lower in the NPWT group compared to conventional dressings (MD = −3.78 days; 95% CI: −6.29 to −1.27; p = 0.003). Two studies reported a lower rate of wound healing complications other than SSIs in the NPWT group (OR = 0.22; 95% CI: 0.05–1.09; p = 0.06). No substantial differences were observed in terms of LOS (MD = −0.02 days; 95% CI: −1.22 to 1.17; p = 0.97) and patient-reported wound cosmesis (SMD = 0.31; 95% CI: −0.49 to 1.11; p = 0.44). The review’s limitations include potential risk of bias, variability in study designs, and heterogeneity between studies. Conclusions: NPWT contributes to improved wound management through reducing wound healing time compared to Non-Pressure Dressings after stoma reversal, although it does not appear to substantially impact SSI rates, LOS, or patient-assessed wound cosmesis. Further large-scale, multicenter RCTs are necessary to validate these results and identify patient populations most likely to benefit from NPWT application. Full article

In this study, a hydrogel material based on porcine gelatin and sodium alginate was synthesized for use as a dressing for chronic wound treatment. The hydrogels were covalently cross-linked using polyethylene glycol diglycidyl ether (PEGDE 500), and the interaction between the components was confirmed via FTIR. The properties of the resulting hydrogels were examined, including gel-fraction volume, swelling degree in different media, mechanical properties, pore size, cytotoxicity, and the ability to absorb and release analgesics (lidocaine, novocaine, sodium diclofenac). The hydrogel’s resistance to enzymatic action by protease was enhanced both through chemical cross-linking and physical interactions between gelatin and alginate. The absorption capacity of the hydrogels, reaching 90 g per dm² of the hydrogel dressing, indicates their potential for absorbing wound exudates. It was demonstrated that the antiseptic (chlorhexidine) contained in the structured gelatin–alginate hydrogels can be released into an infected substrate, resulting in a significant inhibition of pathogenic microorganisms (Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Aspergillus niger). These results clearly demonstrate that the obtained hydrogel materials can serve as non-traumatic dressings for the treatment of chronic and/or infected wounds. Full article

Wound healing remains a critical challenge in healthcare, especially with the increasing prevalence of diabetes and its associated complications, such as diabetic foot ulcers (DFUs). Delayed wound healing in diabetic patients is attributed to several factors, with a pathophysiology that is diverse and multifaceted, including decreased immune responses, microvascular dysfunction, oxidative stress and impaired collagen synthesis. Additionally, the development of an infection at the wound site further complicates and hinders the healing process, especially in DFUs. Epigallocatechin gallate (EGCG), a potent bioactive compound found in green tea, has shown promising effects in modulating various stages of wound healing by its antioxidant, anti-inflammatory and anti-bacterial properties in vitro and in vivo. This review discusses delayed wound healing in diabetic wounds, while highlighting the therapeutic potential of GT/EGCG in different stages of wound healing, including in diabetic wounds both in vitro and in vivo. Novel applications such as GT-/EGCG-loaded wound dressings have demonstrated significant positive impacts on wound healings, including in diabetic wounds, both in in vitro and in vivo studies. Despite its therapeutic potential, the commercial application of green tea in wound care faces significant challenges, including issues of bioavailability, stability, cytotoxicity, production costs, the lack of in-depth and complete in vivo studies and, most importantly, the lack of clinical trials. By consolidating current knowledge and identifying gaps, this review aims to inspire future research and innovations in using green tea for effective wound management and potential use in diabetic patients and DFUs, if the positive results from animal in vivo studies are equally effective in human clinical studies. Full article

The current treatment of radiation-induced skin wounds utilizes mainly conventional therapies, including topical steroids, creams, ointments, and hydrogel dressings, which do not take into account the immunologic changes that occur in the skin after radiation exposure. Therefore, it is relevant to consider alternative therapies and their impact on changes in the immune landscape of the skin. The aim of this study was to investigate the effect of allogeneic minimally manipulated keratinocytes and fibroblasts on rat skin repair and the development of immune responses. We found that the use of cell therapy compared to treatment with syntazone ointment and no treatment resulted in faster healing and a reduction in the size of radiation-induced skin wounds, area of inflammation, and edema. Additionally, in the group receiving the cell therapy application, there was an observed increase in the number of mast cells (MCs), activation of MC interaction with M2 macrophages, a reduction in the direct contact of MCs with the vascular bed, an increase in the content of collagen fibers due to the intensification of collagen fibrillogenesis, and a restoration of their histotopographic organization. Thus, the positive effect of cell therapy based on allogeneic minimally manipulated keratinocytes and fibroblasts on skin regeneration indicated that it can be used in clinical practice to improve the effectiveness of rehabilitation after radiation therapy. Full article

Diabetic wounds are therapeutically challenging because of the complex and adverse microenvironment that impedes healing. Unlike conventional wound dressings, hydrogels provide antibacterial, anti-inflammatory, and repair-promoting functions. In this study, we developed a light-responsive and injectable chitosan methacryloyl (CSMA) hydrogel, incorporating soy isoflavones (SIs) and gold nanoparticles (AuNPs). Transmission electron microscopy (TEM), Fourier transform infrared (FTIR) spectroscopy, and proton nuclear magnetic resonance (1H NMR) spectroscopy analyses confirmed the successful synthesis of the CSMA/SI/AuNP hydrogels. In vitro experiments demonstrated that this hydrogel exhibited exceptional biocompatibility and enhanced the migration of human umbilical vein endothelial cells (p < 0.05), thereby underscoring its potential for promoting angiogenesis. In vivo studies have indicated that hydrogels significantly enhance the rate of wound healing (p < 0.001). Moreover, they facilitate angiogenesis (p < 0.01) and diminish the inflammatory response at the wound site (p < 0.05). Additionally, hydrogels promote collagen deposition and the regeneration of skin appendages. These findings substantiate the hydrogel’s therapeutic potential for diabetic wound care, highlighting its promise for regenerative medicine. CSMA/SI/AuNP represents a significant advancement in diabetic wound treatment, addressing key challenges in wound healing by offering a multifaceted therapeutic approach with broad clinical implications for enhancing patient outcomes in chronic wound management. Full article

Background: In thermal injuries, enzymatic debridement is a viable option for treating partial- and full-thickness burns, allowing for rapid removal of damaged tissue with minimal bleeding and without sacrificing healthy dermis. Enzymatic debridement using Nexobrid^® combined with negative wound pressure therapy (NWPT) appears to promote healing, as enzymatic debridement helps preserve healthy tissue integrity and epithelial reserves. We explored therapeutic alternatives following enzymatic debridement to assess healing outcomes and reduce reliance on skin grafts. Methods: 24 patients with deep or partially deep thermal burns on 5–40% of total body surface area (TBSA) underwent enzymatic debridement; then, half received NWPT and the other half were treated with topicals. Results: Enzymatic debridement effectively removed necrotic tissue and facilitated healing. Only three patients required skin grafts (<10% TBSA). Enzymatic debridement combined with NWPT expedited daily healing, reduced hospitalization days, and eliminated wound secretion, as confirmed by bacteriological examination. This approach was more effective compared to enzymatic debridement followed by topical treatments. Conclusions: Nexobrid^® in combination with NWPT is a promising alternative to surgical treatment, improving healing, reducing the need for skin grafts, and alleviating pain associated with dressing changes. It may be particularly useful in extensive burns, where epithelial reserves are limited. Full article

Background/Objectives. Chronic wounds pose a substantial global healthcare burden exacerbated by aging populations and the increasing prevalence of conditions such as diabetes, peripheral vascular disease, and venous insufficiency. Impaired physiological repair mechanisms, including angiogenesis, collagen synthesis, and re-epithelialization, hinder the healing process in chronic wounds. Many of these physiological processes are dependent on their interaction with copper. We hypothesized that the targeted delivery of copper ions to the wound bed would enhance healing. Methods. Wound dressings impregnated with copper oxide microparticles were designed to ensure the controlled release of copper ions. The efficacy of these dressings was evaluated using non-infected wound models, including diabetic mouse models compared against control and silver dressings. Outcome measures included wound closure rates, epidermal skin quality assessed by histopathological examination, and gene expression profiling. Clinical applications were assessed through diverse case studies and controlled trials involving chronic wound management. Results. Copper dressings significantly accelerated wound closure and enhanced angiogenesis compared to control and silver dressings. Histopathological analyses revealed faster granulation tissue formation, epidermal regeneration, and neovascularization. Gene expression studies showed upregulation of critical angiogenic factors such as VEGF and HIF-1α. Investigations and clinical observations corroborated improved healing across various chronic wound types, including non-infected wounds. Conclusions. Copper is essential for wound healing, and copper-impregnated dressings provide a promising solution for chronic wound management. By enhancing angiogenesis and tissue regeneration, these dressings go beyond antimicrobial action, offering a cost-effective and innovative alternative to conventional therapies. Copper dressings represent a transformative advancement in addressing the challenges of chronic wound care. Full article

The use of blood plasma, fibrinogen or fibrin, a natural biomaterial, has been widely studied for the development of different skin tissue-engineered products and other dermatological treatments. This systematic review reports the preclinical and clinical studies which use it alone or combined with other biomaterials and/or cells for the treatment of several dermatological conditions. Following the PRISMA 2020 Guidelines, 147 preclinical studies have revealed that the use of this biomaterial as a wound dressing or as a monolayer (one cell type) skin substitute are the preferred strategies, mainly for the treatment of excisional or surgical wounds. Moreover, blood plasma is mainly used alone although its combination with other biomaterials such as agarose, polyethylene glycol or collagen has also been reported to increase its wound healing potential. However, most of the 17 clinical reviewed evaluated its use for the treatment of severely burned patients as a wound dressing or bilayer (two cell types) skin substitute. Although the number of preclinical studies evaluating the use of blood plasma as a dermatological treatment has increased during the last fifteen years, this has not been correlated with a wide variety of clinical studies. Its safety and wound healing potential have been proved; however, the lack of a standard model and the presence of several approaches have meant that its translation to a clinical environment is still limited. A higher number of clinical studies should be carried out in the coming years to set a standard wound healing strategy for each dermatological disease. Full article

Background: Wound healing is a complex and intricate biological process that involves multiple systems within the body and initiates a series of highly coordinated responses to repair damage and restore integrity and functionality. We previously identified that breathing hydrogen can significantly inhibit early inflammation, activate autologous stem cells, and promote the accumulation of extracellular matrix (ECM). However, the broader functions and downstream targets of hydrogen-induced ECM accumulation and tissue remodeling are unknown in the wound-healing process. Methods: Consequently, this thesis developed a hydrogen sustained-release dressing based on a micro storage material and reveals the mechanism of hydrogen in treating wound healing. Upon encapsulating the hydrogen storage materials, magnesium (Mg), and ammonia borane (AB), we found that SiO₂@Mg exhibits superior sustained-release performance, while SiO₂@AB demonstrates a higher hydrogen storage capacity. We used a C57/BL6 mouse full-thickness skin defect wound model to analyze and compare different hydrogen dressings. Results: It was identified that hydrogen dressings can significantly improve the healing rate of wounds by promoting epithelialization, angiogenesis, and collagen accumulation in wound tissue, and that the effect of slow-release dressings is better than of non-slow-release dressings. We also found that hydrogen dressing can promote transcriptome-level expression related to cell proliferation and differentiation and ECM accumulation, mainly through the Wnt1/β-catenin pathway and TGF-β1/Smad2 pathway. Conclusions: Overall, these results provide a novel insight into the field of hydrogen treatment and wound healing. Full article

Wound healing is a complex process involving stages such as hemostasis, inflammation, proliferation, and remodeling. In this context, polymers are useful materials for wound treatment. This research used the Casting method to prepare films from 2% polyvinylpyrrolidone (PVP) gels. Subsequently, PVP films were grafted with maleic acid (MA) (PVP-g-PAM) to load naringin (NA) and silver nanoparticles (AgNPs) in order to obtain a material with pH responsiveness and antibacterial properties. The modified PVP-g-PAM films were prepared using gamma-ray irradiation through a pre-irradiation oxidative method at a dose rate of 13.7 kGy h⁻¹, doses ranging from 10 to 25 kGy, and reaction times from 50 to 80 min in a bath of water, all samples at 50 °C, and a fixed monomer concentration of 15% (w/v) MA in THF. The conditions that yielded the highest percentage of grafting were 20 kGy and 60 min. NA was loaded at a fixed concentration of 5%. Data release showed that the films follow the Korsmeyer-Peppas kinetic model. Synthesis of AgNPs was performed by γ-ray irradiation–reduction (10 and 30 kGy), using PVP as a stabilizer. AgNPs showed in vitro effectiveness against E. coli and S. aureus. Films were characterized by FTIR-ATR, TGA, DSC, mechanical properties, swelling index, and contact angle. Further studies must be implemented; however, the results up now suggest that PVP-g-PAM loaded with NA and AgNPs can be useful as a potential wound dressing. Full article

Background/Objectives: Chronic wounds pose a significant health concern, with their prevalence increasing due to various etiologies. The global aging population further contributes to this rise, placing a substantial burden on healthcare systems in developed countries. This work aimed to develop new therapeutic options in the form of creams and dressings based on honey, gellan gum, and hyaluronic acid for preventing and treating chronic wounds across all stages. Methods: To address this, after the formulations were developed, in vitro cytocompatibility was determined. To confirm biocompatibility, an ovine wound model was used: full-thickness excisional wounds were treated with three formulations, namely gellan gum and honey sponges (GG-HNY), gellan gum, honey and hyaluronic acid sponges (GG-HA-HNY) and a honey-based cream (cream FB002). Daily assessments, including visual evaluation and wound scoring, were conducted for 30 days. Following the study period, tissues were collected for histological analyses. Results: The macroscopic examination revealed that all therapeutic groups facilitated lesion closure. Lesion size reduction, granulation tissue disappearance, and scar tissue development were consistent across all groups, with the group receiving cream demonstrating an advanced stage of healing. All groups achieved substantial wound closure by day 30, with no significant differences. Histopathological analysis following ISO standards revealed that GG-HA-HNY had the lowest ISO score, indicating minimal reactivity and inflammation, which corroborated the cytocompatibility. Conclusions: Combining these insights with previous findings enhances our understanding of wound regeneration dynamics and contributes to refining therapeutic strategies for chronic wounds. The formulations were designed to balance therapeutic efficacy with cost-effectiveness, leveraging low-cost raw materials and straightforward production methods. Full article